Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-intensity repetitive transcranial magnetic stimulation is safe and well tolerated by people living with MS - outcomes of the phase I randomised controlled trial (TAURUS).
Nguyen PT, Zarghami A, Makowiecki K, Stevens N, Ezegbe C, Kyle K, Wang C, Ly L, De La Rue K, Hinder MR, Johnson L, Rodger J, Cooper S, Cullen CL, Barnett M, Young KM, Taylor BV. Nguyen PT, et al. Among authors: taylor bv. Mult Scler J Exp Transl Clin. 2024 May 15;10(2):20552173241252571. doi: 10.1177/20552173241252571. eCollection 2024 Apr-Jun. Mult Scler J Exp Transl Clin. 2024. PMID: 38756414 Free PMC article.
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.
Mathey EK, Park SB, Hughes RA, Pollard JD, Armati PJ, Barnett MH, Taylor BV, Dyck PJ, Kiernan MC, Lin CS. Mathey EK, et al. Among authors: taylor bv. J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):973-85. doi: 10.1136/jnnp-2014-309697. Epub 2015 Feb 12. J Neurol Neurosurg Psychiatry. 2015. PMID: 25677463 Free PMC article. Review.
Role of environmental factors in multiple sclerosis.
Zarghami A, Li Y, Claflin SB, van der Mei I, Taylor BV. Zarghami A, et al. Among authors: taylor bv. Expert Rev Neurother. 2021 Dec;21(12):1389-1408. doi: 10.1080/14737175.2021.1978843. Epub 2021 Sep 20. Expert Rev Neurother. 2021. PMID: 34494502 Review.
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study).
Maltby VE, Lea RA, Monif M, Fabis-Pedrini MJ, Buzzard K, Kalincik T, Kermode AG, Taylor B, Hodgkinson S, McCombe P, Butzkueven H, Barnett M, Lechner-Scott J. Maltby VE, et al. JMIR Res Protoc. 2021 Oct 19;10(10):e24969. doi: 10.2196/24969. JMIR Res Protoc. 2021. PMID: 34665152 Free PMC article.
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination.
Zarghami A, van der Mei I, Hussain MA, Claflin SB, Bessing B, Simpson-Yap S, Ponsonby AL, Lechner-Scott J, Broadley S, Blizzard L, Taylor BV; AusLong Investigator Group. Zarghami A, et al. Among authors: taylor bv. Mult Scler. 2022 Oct;28(11):1793-1807. doi: 10.1177/13524585221089900. Epub 2022 May 13. Mult Scler. 2022. PMID: 35549477
Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial.
Makowiecki K, Stevens N, Cullen CL, Zarghami A, Nguyen PT, Johnson L, Rodger J, Hinder MR, Barnett M, Young KM, Taylor BV. Makowiecki K, et al. Among authors: taylor bv. Trials. 2022 Aug 3;23(1):626. doi: 10.1186/s13063-022-06526-z. Trials. 2022. PMID: 35922816 Free PMC article.
264 results